Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125484001 | 12548400 | 1 | I | 20160704 | 20160712 | 20160712 | EXP | NL-AMGEN-NLDSL2016088272 | AMGEN | 0.00 | M | Y | 0.00000 | 20160712 | CN | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125484001 | 12548400 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 0.65 ML (200MCG/ML), Q4WK | 103951 | .65 | ML | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125484001 | 12548400 | 1 | Nephrogenic anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125484001 | 12548400 | OT |
| 125484001 | 12548400 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125484001 | 12548400 | Dialysis | |
| 125484001 | 12548400 | Hospitalisation | |
| 125484001 | 12548400 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |